OVID Research and Charts

OVID - Ovid Therapeutics Inc (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2026-02-10)

Last 1.64	Change ⇑ +0.06 (+3.80%)	Volume 1,165,555
	Open 1.58	High 1.65	Low 1.57

8EMA (Daily) 1.58	40EMA (Daily) 1.60	50EMA (Daily) 1.59	STO (Daily) 34.091	MACD Hist (Daily) 0.008
8EMA (Weekly) 1.621	40EMA (Weekly) 1.32	50EMA (Weekly) 1.29	STO (Weekly) 61.714	MACD Hist (Weekly) -0.040


Company Profile
Ovid Therapeutics Inc is a US based biopharmaceutical company. The firm is primarily engaged in developing impactful medicines for patients and families living who are suffering with rare neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patient's life.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.